novel
carbamoylcarbazid
deriv
nonsteroid
antiinflammatori
drug
ibuprofen
fenoprofen
reduc
ketoprofen
prepar
fulli
chemic
character
evalu
cytostat
antivir
antioxid
activ
compound
consist
region
rich
electroneg
atom
five
nine
nitrogen
oxygen
atom
frame
aryl
cycloalkyl
residu
one
termin
end
synthet
pathway
appli
prepar
titl
compound
involv
benzotriazol
synthet
auxiliari
sever
step
three
test
compound
name
propanoyl
semicarbazid
propanoyl
semicarbazid
propanoyl
semicarbazid
show
pronounc
antiprolif
activ
vitro
six
cancer
cell
line
ic
mm
compound
highli
inhibit
soybean
lipoxygenas
ic
mm
lipid
peroxid
well
respect
propanoyl
semicarbazid
propanoyl
carbazid
exert
complet
lipid
peroxid
inhibit
semicarbazid
carbazid
bear
hydroxam
acidhydroxyurea
moieti
show
modest
antirad
activ
dpph
test
best
radic
scaveng
none
compound
inhibitori
broad
panel
dna
rna
virus
cell
cultur
subtox
concentr
novel
carbamoylcarbazid
deriv
nonsteroid
antiinflammatori
drug
ibuprofen
fenoprofen
reduc
ketoprofen
prepar
fulli
chemic
character
evalu
cytostat
antivir
antioxid
activ
compound
consist
region
rich
electroneg
atom
five
nine
nitrogen
oxygen
atom
frame
aryl
cycloalkyl
residu
one
termin
end
synthet
pathway
appli
prepar
titl
compound
involv
benzotriazol
synthet
auxiliari
sever
step
three
test
compound
name
propanoyl
semicarbazid
propanoyl
semicarbazid
propanoyl
semicarbazid
show
pronounc
antiprolif
activ
vitro
six
cancer
cell
line
ic
mm
compound
highli
inhibit
soybean
lipoxygenas
ic
mm
lipid
peroxid
well
respect
propanoyl
semicarbazid
propanoyl
carbazid
exert
complet
lipid
peroxid
inhibit
semicarbazid
carbazid
bear
hydroxam
acidhydroxyurea
moieti
show
modest
antirad
activ
dpph
test
best
radic
scaveng
none
compound
inhibitori
broad
panel
dna
rna
virus
cell
cultur
subtox
concentr
elsevi
masson
sa
right
reserv
chronic
inflamm
common
import
factor
pathogenesi
neoplasma
inflamm
often
accompani
excess
format
reactiv
oxygen
nitrogen
speci
potenti
damag
dna
cell
membran
addit
express
inflammatori
neoplast
cell
impact
variou
carcinogen
pathway
nsaid
use
chemoprevent
welldocu
numer
experiment
epidemiolog
clinic
studi
found
longterm
use
nsaid
associ
lower
risk
colorect
cancer
adenomat
polyp
type
cancer
nsaid
chemic
modif
undertaken
aim
improv
nsaid
safeti
profil
increas
analgeticantiinflammatori
activ
select
reduc
ulcerogen
effect
obtain
dual
coxlox
inhibit
mani
effort
made
get
nsaid
deriv
pronounc
cytostat
activ
well
thu
set
prepar
seri
new
nsaid
deriv
rich
nitrogenoxygen
atom
relat
semicarbazid
carbazid
urea
hydroxyurea
hydroxam
acid
bear
pharmacophor
present
numer
antitumor
agent
synthesi
full
chemic
character
evalu
cytostat
antivir
antioxid
potenti
report
paper
melt
point
determin
stuart
melt
point
apparatu
uncorrect
ir
spectra
record
ftir
perkineelm
paragon
spectromet
uvevis
doubl
beam
spectrophotomet
lambda
perkineelm
use
vitro
test
h
c
nmr
spectra
record
bruker
spectromet
oper
mhz
h
mhz
c
nuclei
sampl
measur
dmsod
solut
c
mm
nmr
tube
chemic
shift
ppm
refer
tm
chn
analys
perform
chn
leco
analyz
within
solvent
system
dichloromethanemethanol
cyclohexaneethyl
acet
petroleum
ether
ethyl
acetatemethanol
precoat
silica
gel
f
plate
use
thinlay
chromatographi
spot
visual
shortwav
uv
light
iodin
vapor
phosphomolybd
acid
ferric
chlorid
solut
column
chromatographi
perform
silica
gel
mm
cyclohexan
ethyl
acetatemethanol
dichloromethanemethanol
eluent
propano
acid
prepar
ketoprofen
reduct
carboxyl
acid
chlorid
btccl
nsaid
ibuprofen
fenoprofen
reduc
ketoprofen
benzotriazolid
synthes
accord
previous
publish
procedur
prepar
nalkyl
arylcarbamoyl
benzotriazol
carboxyl
acid
amid
synthet
method
appli
well
follow
deriv
prepar
ncyclopentylcarbamoyl
benzotriazol
ncyclohexylcarbamoyl
benzotriazol
ncyclohexanemethylcarbamoyl
benzotriazol
nbenzylcarbamoyl
benzotriazol
n
benzotriazol
nbenzhydrylcarbamoyl
benzotriazol
nbenzyloxycarbamoyl
benzotriazol
benzotriazol
bth
triphosgen
obenzylhydroxylamin
hydrochlorid
cyclopentylamin
cyclohexylamin
cyclohexanemethylamin
benzylamin
benzhydrylamin
hydrazin
hydrat
triethylamin
tea
pdc
purchas
aldrich
ibuprofen
fenoprofen
ketoprofen
gift
sampl
pliva
univers
potchefstroom
belupo
dpph
aaph
ndga
purchas
aldrich
chemic
co
soybean
lox
linol
acid
sodium
salt
obtain
sigma
chemic
co
solvent
analyt
grade
puriti
dri
solut
hydrazin
hydrat
ml
mmol
dioxan
ml
solut
nsaid
benzotriazolid
mmol
dioxan
ml
ad
dropwis
reaction
mixtur
stir
rt
h
evapor
reduc
pressur
obtain
residu
dissolv
ethyl
acet
ml
method
melt
mixtur
nsaid
hydrazid
mmol
mmol
tea
ml
mmol
stir
c
min
residu
cool
room
temperatur
dissolv
ethyl
acet
ml
extract
sodium
hydroxid
solut
ml
organ
layer
wash
water
dri
anhydr
sodium
sulfat
evapor
reduc
pressur
method
b
melt
mixtur
nsaid
hydrazid
mmol
mmol
tea
ml
mmol
stir
c
min
residu
cool
room
temperatur
stir
acetonehcl
solut
ml
ph
precipit
product
b
filter
method
c
solut
nsaid
hydrazid
mmol
g
mmol
nbenzyloxycarbamoyl
benzotriazol
dioxan
ml
stir
c
h
dioxan
evapor
reduc
pressur
residu
dissolv
ethyl
acet
ml
extract
sodium
hydroxid
solut
ml
organ
layer
wash
water
dri
anhydr
sodium
sulfat
evapor
reduc
pressur
method
solut
semicarbazid
mmol
methanol
ml
hydrogen
h
presenc
pdc
mg
catalyst
filter
solvent
evapor
reduc
pressur
solut
nbenzyloxycarbamoyl
benzotriazol
g
mmol
ml
dioxan
ad
dropwis
solut
ml
mmol
hydrazin
hydrat
ml
dioxan
reaction
mixtur
stir
rt
h
evapor
reduc
pressur
analyt
pure
sampl
obtain
column
chromatographi
dichloromethanemethanol
tritur
cytostat
activ
test
compound
murin
leukemia
human
lymphocyt
cem
cervix
carcinoma
hela
cell
determin
follow
cem
hela
cell
suspend
cellsml
cultur
medium
ml
cell
suspens
ad
ml
appropri
dilut
test
compound
mlwell
microtit
plate
incub
c
two
three
cem
hela
day
cell
number
determin
use
coulter
counter
wherea
cem
cell
could
count
directli
coulter
counter
hela
cell
detach
microtit
plate
well
trypsin
treatment
prior
count
ic
defin
compound
concentr
requir
inhibit
cell
prolifer
cytostat
activ
test
compound
hct
colon
carcinoma
h
lung
carcinoma
breast
carcinoma
hacat
human
immort
keratinocyt
determin
follow
cell
cultur
monolay
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
uml
penicillin
mgml
streptomycin
humidifi
atmospher
co
c
growth
inhibit
activ
assess
describ
previous
panel
cell
line
inocul
onto
seri
standard
microtit
plate
day
cellsml
depend
doubl
time
specif
cell
line
test
agent
ad
tenfold
dilut
incub
h
work
dilut
freshli
prepar
day
test
h
incub
cell
growth
rate
evalu
perform
mtt
assay
detect
dehydrogen
activ
viabl
cell
absorb
measur
micropl
reader
nm
absorb
directli
proport
number
live
metabol
activ
cell
percentag
growth
pg
cell
line
calcul
accord
one
follow
two
express
test
mean
tzero
pg
test
mean
tzero
ctrl
mean
tzero
mean
tzero
averag
optic
densiti
measur
exposur
cell
test
compound
mean
test
averag
optic
densiti
measur
desir
period
time
mean
ctrl
averag
optic
densiti
measur
desir
period
time
exposur
cell
test
compound
result
express
ic
concentr
necessari
inhibit
ic
valu
compound
calcul
concentrationerespons
curv
use
linear
regress
analysi
fit
test
concentr
give
pg
valu
refer
valu
ie
howev
test
concentr
produc
pg
exceed
respect
refer
level
effect
eg
pg
valu
highest
test
concentr
assign
default
valu
preced
sign
test
perform
quadrupl
least
two
individu
experi
antivir
assay
antihiv
assay
base
inhibit
virusinduc
cytopath
effect
human
lung
fibroblast
ethanol
solut
dpph
mm
absolut
ethanol
equal
volum
compound
final
concentr
mm
dissolv
dmso
ad
mixtur
shaken
vigor
allow
stand
min
absorb
nm
determin
spectrophotometr
percentag
activ
calcul
test
undertaken
three
replic
result
averag
tabl
watersolubl
azo
compound
aaph
use
free
radic
initi
vitro
studi
free
radic
product
product
conjug
dien
hydroperoxid
oxid
linol
acid
sodium
salt
aqueou
solut
monitor
nm
assay
use
follow
oxid
chang
understand
contribut
test
compound
amount
ml
mm
linol
acid
sodium
salt
solut
ad
uv
cuvett
contain
ml
phosphat
buffer
ph
prethermost
c
oxid
reaction
initi
c
air
addit
ml
mm
aaph
solut
oxid
carri
presenc
aliquot
ml
assay
without
antioxid
lipid
oxid
measur
presenc
level
dmso
rate
oxid
c
monitor
record
increas
absorpt
nm
caus
conjug
dien
hydroperoxid
experi
perform
least
triplic
standard
deviat
absorb
less
mean
test
compound
dissolv
dmso
incub
room
temperatur
sodium
linol
ml
ml
enzym
solut
part
part
salin
wv
salin
convers
sodium
linol
acid
nm
record
compar
appropri
standard
inhibitor
experi
perform
least
triplic
standard
deviat
absorb
less
mean
two
seri
nitrogenoxygenrich
deriv
nsaid
ibuprofen
fenoprofen
reduc
ketoprofen
tabl
inhibitori
effect
semicarbazid
carbamoylcarbazid
intermedi
compound
prolifer
malign
tumor
cell
line
structur
formula
tumor
cell
growth
ic
prepar
contain
region
five
nine
electroneg
atom
three
nitrogen
plu
two
three
oxygen
atom
five
nitrogen
plu
four
oxygen
atom
frame
aryl
cycloalkyl
hydroxi
residu
one
termin
end
therefor
close
relat
semicarbazid
carbazid
urea
hydroxyurea
hydroxam
acid
first
seri
involv
semicarbazid
bear
nsaid
acyl
residu
posit
cycloalkyl
aryl
benzyloxi
hydroxi
substitu
posit
semicarbazid
backbon
compound
prepar
nsaid
hydrazid
correspond
nalkylarylcarbamoyl
benzotriazol
carboxyl
acid
amid
scheme
hydrazid
previous
describ
new
compound
report
new
method
effici
hydrazid
prepar
nsaid
benzotriazolid
hydrazin
hydrat
nalkylarylcarbamoyl
benzotriazol
synthes
carboxyl
acid
chlorid
btccl
correspond
amin
follow
previous
publish
procedur
benzyloxysemicarbazid
hydrogenolysi
benzyl
group
gave
carbazid
seri
compound
prepar
reaction
nsaid
hydrazid
compound
hydrogenolysi
obtain
carbazid
compound
prepar
btccl
obtain
nbenzyloxycarbamoyl
benzotriazol
hydrazin
scheme
synthet
pathway
appli
prepar
major
compound
involv
benzotriazol
synthet
auxiliari
benzotriazol
moieti
compound
activ
molecul
nucleophil
substitut
hydrazin
hydrat
hydrazid
allow
prepar
hydrazid
semicarbazid
carbazid
mild
condit
reaction
hydrazid
act
acyl
donor
also
nucleophil
via
termin
nitrogen
atom
benzotriazol
introduc
intermedi
product
mean
carboxyl
acid
chlorid
btccl
first
describ
research
group
commerci
avail
tea
use
catalyst
andor
hcl
acceptor
sever
synthet
step
reaction
g
k
avoid
possibl
cycliz
final
step
prepar
perform
solventfre
system
reaction
run
minim
temperatur
afford
melt
c
reaction
condit
allow
complet
reaction
less
min
good
yield
structur
synthes
compound
support
ir
h
c
nmr
spectra
confirm
element
analysi
chemic
shift
consist
propos
structur
novel
compound
detail
nmr
data
given
tabl
support
inform
target
compound
well
synthet
precursor
evalu
inhibitori
activ
prolifer
follow
malign
tumor
cell
line
murin
leukemia
human
tlymphocyt
cem
human
cervic
carcinoma
hela
human
colon
carcinoma
hct
human
breast
carcinoma
human
lung
carcinoma
tabl
test
compound
discrimin
much
differ
tumor
cell
line
regard
cytostat
activ
except
human
mammari
carcinoma
cell
gener
sensit
antiprolif
activ
compound
carcinoma
cell
line
tabl
activ
compound
propanoyl
semicarbazid
propanoyl
semicarbazid
propanoyl
semicarbazid
inhibit
tumor
cell
prolifer
ic
valu
rang
mm
strike
observ
three
activ
compound
consist
contain
uniqu
structur
motif
ie
wherea
lack
bulki
aromat
cycloalkyl
group
result
free
endstand
econhnh
econhoh
group
virtual
annihil
cytostat
activ
thu
presenc
bulki
lipophil
group
prefer
benzhydryl
group
strictli
requir
termin
end
would
interest
introduc
addit
substitu
benzhydryl
moieti
ie
alkyl
alkoxi
halogen
amin
carboxyl
acid
andor
hydroxyl
group
explor
cytostat
potenti
select
test
compound
nsaid
termin
molecul
seem
less
import
ie
isobutyl
phenoxyphenyl
benzyl
determin
antiprolif
potenc
would
also
interest
explor
addit
sar
modifi
latter
part
molecul
addit
test
select
compound
nontumor
cell
line
hacat
human
keratinocyt
show
activ
deriv
may
exert
slight
select
toward
tumor
cell
specif
solid
tumor
cell
compar
nontumor
cell
two
time
lower
ic
concentr
tumor
cell
line
compound
gener
show
inhibitori
effect
toward
tumor
nontumor
cell
line
except
toward
breast
cancer
cell
shown
slightli
sensit
still
result
interpret
caution
without
detail
experi
andor
specif
target
identif
although
cell
tumorigen
immort
rel
short
doubl
time
howev
test
nsaid
deriv
show
much
lower
toxic
toward
hacat
compar
refer
compound
cisplatin
none
test
compound
inhibitori
subtox
concentr
broad
panel
dna
rna
virus
cell
cultur
report
mani
nsaid
act
either
inhibitor
free
radic
product
radic
scaveng
show
reduct
lipid
peroxid
also
show
less
ulcerogen
activ
present
investig
vitro
antioxid
abil
new
nsaid
deriv
precursor
synthesi
studi
compar
wellknown
antioxid
agent
nordihydroguaiaret
acid
ndga
acid
trolox
two
differ
antioxid
assay
use
interact
stabl
free
radic
radic
dpph
ii
interact
watersolubl
azo
compound
azobi
hydrochlorid
aaph
use
sourc
peroxyl
radic
dpph
interact
test
compound
examin
mm
concentr
min
result
shown
tabl
show
best
dpph
interact
valu
similar
refer
compound
ndga
concentr
semicarbazid
seri
carbazid
seri
compound
low
lipophil
valu
bear
hydroxam
acidhydroxyurea
moieti
show
weak
interact
dpph
antioxid
activ
increas
min
studi
aaph
use
free
radic
initi
follow
oxid
chang
linol
acid
conjug
dien
hydroperoxid
result
show
almost
equipot
complet
inhibit
lipid
peroxid
lp
two
compound
also
inhibit
lp
better
trolox
respect
signific
differ
observ
compound
seri
hydrazid
complet
inact
result
like
report
data
indic
lp
inhibit
alway
accompani
dpph
radic
scaveng
activ
thu
compound
inhibit
lp
potent
exert
low
dpph
scaveng
activ
carcinogenesi
multistag
process
consist
least
three
separ
close
link
process
initi
promot
progress
promot
close
link
oxid
tabl
interact
dpph
vitro
inhibit
lipid
peroxid
lp
soybean
lipoxygenas
lox
theoret
calcul
c
log
p
valu
inflammatori
tissu
damag
convers
substanc
potent
antiinflammatori
andor
antioxid
activ
anticip
exert
chemoprevent
effect
carcinogenesi
particularli
stage
promot
act
antitumor
promot
take
consider
mention
well
antioxid
cytostat
activ
compound
seem
three
five
activ
lp
inhibitor
strongest
antiprolif
agent
well
find
support
idea
cytostat
activ
highli
correl
antioxid
potenti
antilipid
peroxid
activ
gener
inform
obtain
antioxid
activ
may
help
understand
anticanc
properti
compound
known
metal
especi
iron
copper
play
key
role
free
radic
gener
propag
therefor
metal
chelat
act
protector
could
partli
possibl
mechan
action
lipoxygenas
lox
play
signific
role
membran
lipid
peroxid
form
hydroperoxid
lipid
bilay
biotransform
arachidon
acid
catalyz
lox
lox
inhibitor
attract
attent
initi
potenti
agent
treatment
inflammatori
allerg
diseas
certain
type
cancer
cardiovascular
diseas
order
diminish
procancer
mechan
key
treatment
strategi
reduc
free
radic
load
antioxid
activ
scaveng
reactiv
oxygen
speci
import
prevent
potenti
damag
cellular
macromolecul
dna
protein
lipid
moreov
found
lox
inhibitor
may
chemoprevent
activ
lung
carcinogenesi
report
publish
past
three
decad
support
growthregulatori
role
arachidon
acid
metabolit
etiolog
mammari
carcinogenesi
studi
demonstr
level
sever
eicosanoid
increas
breast
cancer
comparison
benign
breast
tumor
context
decid
evalu
newli
prepar
nsaid
deriv
abil
inhibit
soybean
lox
shown
inhibit
plant
lox
activ
nsaid
qualit
similar
inhibit
rat
mast
cell
lox
may
use
simpl
qualit
screen
activ
test
deriv
present
interest
ic
valu
mm
comparison
ic
valu
refer
ndga
mm
tabl
two
contain
benzhydryl
third
one
benzyl
substitu
semicarbazid
posit
indic
presenc
bulki
lipophil
group
termin
end
strictli
requir
better
lox
inhibitori
activ
fact
compound
high
c
log
p
valu
respect
support
find
lipophil
import
physicochem
properti
lox
inhibitor
howev
compound
highest
c
log
p
valu
activ
present
inhibit
mm
concentr
sinc
lipophil
signific
physicochem
properti
determin
distribut
bioavail
metabol
activ
elimin
calcul
lipophil
valu
prepar
compound
c
log
p
valu
c
log
p
programm
biobyt
corp
bth
scheme
synthesi
semicarbazid
carbamoylcarbazid
deriv
nsaid
ibuprofen
fenoprofen
reduc
ketoprofen
two
seri
compound
deriv
three
select
arylpropion
acid
name
ibuprofen
fenoprofen
reduc
ketoprofen
synthes
evalu
cytostat
potenti
test
compound
vari
much
cytostat
activ
intermedi
product
display
weak
inhibitori
activ
prolifer
test
tumor
cell
line
opposit
report
carbazid
pharmacophor
econhoh
identifi
hydroxam
acid
hydroxyurea
also
complet
inact
obenzyl
deriv
show
slightli
better
activ
ic
valu
rang
mm
semicarbazid
free
benzyl
protect
hydroxi
group
show
low
activ
well
howev
bear
cycloalkyl
aryl
substitu
cyclopentyl
cyclohexyl
cyclohexylmethyl
benzyl
phenylethyl
benzhydryl
posit
exert
cytostat
activ
examin
malign
tumor
cell
line
slight
select
particular
benzhydrylsubstitut
compound
show
pronounc
cytostat
potenti
inde
bear
highli
lipophil
benzhydryl
group
show
mark
antiprolif
activ
vitro
varieti
cancer
cell
line
ic
mm
compound
profoundli
inhibit
soybean
lipoxygenas
lipid
peroxidas
ibuprofen
benzhydryl
analog
slightli
less
activ
ic
mm
cytotox
inhibit
lox
lp
inhibit
respect
best
antiscaveng
activ
semicarbazid
carbazid
deriv
show
hydroxam
acidhydroxyurea
function
group
low
calcul
lipophil
valu
accord
report
find
howev
compound
show
best
dpph
interact
valu
test
compound
highest
lp
inhibit
show
compound
follow
result
indic
lp
inhibitori
activ
alway
accompani
dpph
radic
scaveng
activ
compound
show
best
lox
inhibitor
cytostat
activ
highli
correl
antioxid
potenti
compound
depict
activ
pattern
may
suggest
similar
mechan
action
correl
antioxid
activ
result
biolog
test
point
compound
lead
compound
derivat
search
effect
antiprolif
lplox
inhibitori
agent
detail
studi
antioxid
activ
along
elucid
specif
target
pathway
mediat
activ
especi
breast
cancer
model
next
step
toward
novel
antioxidantchemoprevent
compound
discoveri
